Multiple myeloma, version 1.2013: Featured updates to the NCCN guidelines

Kenneth C. Anderson, Melissa Alsina, William Bensinger, J. Sybil Biermann, Adam D. Cohen, Steven Devine, Benjamin Djulbegovic, Edward A. Faber, Cristina Gasparetto, Francisco Hernandez-Illizaliturri, Carol Ann Huff, Adetola Kassim, Amrita Y. Krishnan, Michael Liedtke, Ruby Meredith, Noopur Raje, Jeffrey Schriber, Seema Singhal, George Somlo, Keith Stockerl-GoldsteinSteven P. Treon, Donna Weber, Joachim Yahalom, Furhan Yunus, Dorothy A. Shead, Rashmi Kumar

Research output: Contribution to journalArticlepeer-review

Abstract

These NCCN Guidelines Insights highlight the important updates/changes specific to the management of relapsed or progressive disease in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Multiple Myeloma. These changes include the addition of new regimens as options for salvage therapy and strategies to mitigate the adverse effects and risks associated with newer regimens for the treatment of multiple myeloma.

Original languageEnglish (US)
Pages (from-to)11-17
Number of pages7
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2013

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Multiple myeloma, version 1.2013: Featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this